Lumira Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 11
Professionals
  • Investments
  • 146
  • Portfolio
  • 34
  • Exits
  • 69
Exits

Lumira Ventures General Information

Description

Founded in 1989, Lumira Ventures is a venture capital firm based in Toronto, Canada. The firm seeks to invest in companies innovative biotherapeutics, medical technologies, and consumer health solutions.

Contact Information

Formerly Known As
Lumira Capital
Year Founded
1989
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
Primary Investor Type
Venture Capital
Primary Office
  • 141 Adelaide Street
  • Suite 770
  • Toronto, Ontario M5H 3L5
  • Canada
+1 (416) 000-0000

Lumira Ventures Investments (146)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Congruence Therapeutics 08-Feb-2022 Seed Round 0000 Drug Discovery Startup
00000000 000000000 16-Dec-2021 0000 00000 Biotechnology Pre-Clinical Trials 000000 0é00 00
0000000 0000000000 08-Dec-2021 00000 00000 0000 Drug Discovery Generating Revenue 00000000 00000000 00.0
0000 00000000000 16-Nov-2021 00000 00000 0000 Biotechnology Generating Revenue 00000000 00000000 00.0
000000 00000000000 03-Nov-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000000 00000000 00.0
000000 00000000000 02-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue 00000000 00000000 00.0
00000 24-Oct-2021 0000 00000 00.000 Biotechnology Pre-Clinical Trials 00000 00000
000 000000000000 10-Aug-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 000000 0é00 00
BioTheryX 21-May-2021 Later Stage VC 0000 Drug Discovery Generating Revenue
Antios Therapeutics 09-Apr-2021 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 2 00000000 00000000 00.0
You’re viewing 10 of 146 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lumira Ventures Exits (69)

Company Name Exit Date Exit Type Exit Size
Gladius Pharmaceuticals 03-May-2022 Out of Business
0000000 0000000 01-Feb-2021 000000000 00000000
0000000 01-Feb-2021 000000000 00000000
00000 00000000 23-Dec-2020 0000000 000000
000000000 22-Oct-2020 000 00 00000000
0000000 21-Sep-2020 000000000000000000
000000 00000000000 26-Jun-2020 000 00000
000000 00000000000 05-Jun-2020 000000000000000000 00000
Satsuma Pharmaceuticals 13-Sep-2019 IPO 000.00
Essa Pharma 23-Aug-2019 Public Investment 2nd Offering 0000
You’re viewing 10 of 69 exits. Get the full list »

Lumira Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Lumira Ventures‘s full profile, request access.

Request a free trial

Lumira Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lumira Ventures Team (33)

Name Title Deals Funds Boards Office
Vasco Larcina Chief Financial Officer Toronto, Canada
Benjamin Rovinski Ph.D Managing Director 00 0 0 Toronto, Canada
Daniel Hétu MD Managing Director 00 0 0 Montreal, Canada
Gerry Brunk Managing Director 00 0 0 Waltham, MA
Peter van der Velden Managing General Partner 00 0 0 Toronto, Canada
You’re viewing 5 of 33 team members. Get the full list »